Biotech Stock News Alert; Q1 Publishing Research Featuring Verisante Technology, Inc. (TSX-V: VRS) (OTC: VRSEF)
May 9, 2011 - Investorideas.com newswire; The following biotech stock report is issued by Q1 Publishing Research covering Verisante Technology, Inc. (TSX-V: VRS) (PINK SHEETS: VRSEF).
Investorideas.com Newswire features third party research and equity reports from multiple research firms in the industry.
To view a profile on the Company as aired on BTV, click on the following link
http://www.youtube.com/verisante#p/u/2/PHugTxLXQGI
To view the Zacks Investment Research Initiation Report, click on the following link:
http://verisante.com/docs/verisante_zacks.pdf
To view media articles and stories on the Company, click on the following link:
http://verisante.com/news/media/
Jump on this Rapidly Unfolding Med-Tech Innovation Now
By Andrew Mickey, Q1 Publishing
We've only had this feeling a few times before.
It's the feeling we're onto something big - real big - at a very early state.
The same feeling we had about fertilizer stocks in July 2006. The same feeling about the Nintendo Wii when it exploded in Japan and its US launch was still months away. Or when Intuitive Surgical's robotic surgery technology was just making it into hospitals.
You know the feeling you're sitting on your next five- or 10-bagger, you understand it, you know it's big, and you're just waiting for everyone else to figure it out.
Frankly, it's a rare feeling. It's even rarer in a market like this where everything seems priced for perfection.
It's rare, but it's not impossible. Right now, we've got that feeling one small and fast-growing company is about to change a lucrative medical field for the better. And do it soon.
But we're not alone here. Some of the leading medical journals and magazines see the enormous potential we've spotted.
Biotechnology Focus magazine calls this development "ingenious."
The BC Medical Journal says, "Preliminary clinical results have so far demonstrated 100% efficacy."
Darrell Rigel, a professor of dermatology at NYU's Langone Medical Center, told MIT's Technology Review journal there's "a need" for innovations like this.
Despite the medical community's excitement, it still hasn't gone mainstream…yet.
Our window of opportunity to buy into Verisante Technology (TSX-V: VRS or OTCQX: VRSEF) will not be open forever.
Right now Verisante is a small $35 million company, just on the verge of leading medical technology revolution, has shown stellar preliminary clinical results, and based on market comparables is a ten-bagger-in-waiting.
In a few months, all that will be history and Verisante will be value much higher. Let's start at the beginning.
The Next Big Med-Tech Winner
If you're like me, you've learned (the hard and often expensive way) to become highly skeptical when it comes to new technologies.
They consistently over promise and under deliver.
Well, I think Verisante has under promised and is set to over deliver.
Verisante is aquickly emerging medical technology (med-tech) company which, despite its small size, is on the verge of doing something truly revolutionary.
The technology has been in development for 10 years. Its development has been led by some of the world's leading cancer researchers. It has received funding from leading cancer research organizations including the BC Cancer Society.
And, although it's technology has the potential to change almost every field of medicine, it's initially focused on a subsector of the medical field that's overdue for innovation.
Now with a recent $5 million capital infusion to take it to final commercialization, Verisante is poised to make it very big, very soon.
10 Years of Development About to Pay Off
Verisante is has entered the final approval stages for its proprietary cancer screening device.
On the surface, Verisante's Aura device is really simple. It detects cancerous cells by an advanced laser scanning system. And it does it with an astonishing rate of accuracy.
Think of a price scanner at the grocery store. It scans a bar code and tells you the price. Verisante's Aura concern detection device scans a skin lesion and tells you if it's cancerous. (For a complete explanation of how it works, follow this link to a recent feature on Canada's BTV)
Again, it really is a simple concept. But the science behind it is much more advanced than that.
Most importantly though, the Aura has shown the potential to revolutionize cancer detection and save a lot of lives and money in the process.
Verisante has targeted melanoma, one of the most feared and costly to treat cancers, for its initial launch.
Future Market Domination
The Aura device has shown remarkable accuracy and consistency in detecting melanoma at a very early stage (more details below).
Skin cancer is one of the most common forms of cancer. More than two million Americans are diagnosed with it each year. It will affect one in five US residents. And at least 40% of Americans can expect to get non-melanoma skin cancer before they turn 65.
Melanoma specifically one of the most deadly types of cancer. If detected in the Stage I it has an 85% survival rate. In Stage IV the survival rate falls to an ominous 15%.
Melanoma and skin cancer is costly too. It costs $1.5 billion a year to treat melanoma alone.
Despite the high costs of treatment and its deadly nature, there has been little advancement in detection.
For decades, dermatologists have relied on their eyes and patients to self-identify abnormal growth in moles and skin lesions. These crude methods successfully identify about one in three cases of melanoma.
Recently, however, the markets had high expectations that one of Verisante's competitors made a major breakthrough in melanoma detection. And investors were willing to pay top dollar merely speculating the technology worked effectively and consistently enough for regulatory approval.
Why Verisante is a True 10-Bagger
Knowing differences between the Verisante's and MELA Sciences (NASDAQ:MELA) - Verisante's closes competitor - devices reveals the true opportunity here.
MELA has been one of the most closely watched med-tech device stocks over the last year.
MELA's melanoma detection device, MelaFind, was in the final stages of regulatory approval heading into the end of 2010.
Investors were willing to risk getting in early because the upside potential was massive. If approved, MELA would be dominating a mult-billion dollar market virtually overnight.
MELA shares ran to more than $9 per share in anticipation of U.S. Food and Drug Administration (FDA) approval. At its peak, the total market value exceeded $200 million. Keep in mind, MelaFind is only aimed at melanoma and not the many other cancers Verisante's Aura has the potential to be used to detect. And it still was worth $200 million.
Then last November the FDA rejected MELA's device and its shares plummeted.
But here's the thing, MELA's device was rejected for a number of reasons that Verisante will not be affected by.
MELA was rejected because of its low degree of accuracy and large number of false positives.
In my opinion, MelaFind was basically not much more effective than what a dermatologist can determine just by looking at a suspicious mole.
The FDA requires a device to have a certain level of accuracy and consistency. MelaFind had neither.
Now MELA is going to need more studies and more capital to complete those studies. Yet it still has a market value almost three times higher than Verisante.
Key to Success: The Molecular Signature
The key difference between MELA's device and Verisante's is how they identify potentially cancerous cells.
MelaFind takes a picture of a mole or lesion. It then analyzes it against a database of images of confirmed melanoma cases. It uses a proprietary algorithm to compare shapes, sizes, and abnormalities of the lesions. This method didn't produce the accuracy or consistency required by the FDA.
Verisante's device works in a completely different way.
The Aura device analyzes what I call the "molecular signature" of the mole or lesion to determine whether it's likely cancerous or not.
The Aura uses Raman spectroscopy to detect the potential cancer at the molecular level. The studies conducted on the Aura device confirm how effective this process is.
In a six-year clinical trial conducted at the University of British Columbia's dermatology department and Vancouver General Hospital (which has 80,000 dermatoligical patients per year), the Aura device has detected melanoma with incredible accuracy and consistency.
Over a preliminary sample of 274 lesions, the Aura identified 45 melanoma occurrences. Thirty four of those occurrences identified by Aura were confirmed by a biopsy.
These preliminary results give melanoma a 100% accuracy rate and, as a testament to the reliability of the device, a 70% specificity.
These rates are critical part of the regulatory review process. The accuracy rate shows Aura works. The specificity rate shows Aura doesn't give too many "false positive" diagnoses. After all, you can't have a device that gives too many false positives. It would be worthless if it did.
This kind of accuracy and specificity is the critical difference for Verisante. And it shows how revolutionary this product is.
But it takes more than a better mousetrap to be successful. And Verisante has laid out a business model that has been exceptionally profitable for many of the leading companies in the world.
A Dermatologist's Perspective
The most impressive part of Verisante is its business model for commercializing the Aura device.
Once the Aura is approved, Verisante has planned a way to generate a profit by both selling its Aura devices and still earning an ongoing stream of revenue.
Verisante is using the "razor and blade model."
Do you think Gillette makes a lot of money selling a Mach 3 razor for $12? They do, but they make a lot more selling $4 razors month after month after month. Verisante is using the same strategy.
Let's take it from a dermatologist's perspective.
A skin doctor would be able to buy an Aura device and generate a lot of revenue from it. They would be able to charge anywhere from $100 to $500 for a cancer screening and do it for thousands of patients each year.
Many, I'm sure, would be able to pay at least $50,000 for a device that could generate between $100,000 to $1 million a year in revenue from it.
Verisante will likely be able to be able to build Aura devices for about $10,000. This will likely improve as demand increases and economies of scale are achieved, but let's take the more conservative $10,000 estimate. Verisante would be able to sell the device for between $30,000 and $60,000 to dermatologists.
That's a solid margin. The real money, however, comes from the continuous revenue it would receive. The "blades" part of the razor and blade model.
Each screening with the Aura device requires a new tip. The tip includes a lens and other proprietary features to prevent misdiagnosis. Verisante sells the specialized tips required for each use. The tips would likely cost dermatologists $10 each and significantly less to produce.
Verisante would be generating between $20,000 and $50,000 in gross profit per sale of each device. Then it would generate anywhere from $10,000 to $100,000 in additional revenues from the specialized tips from each device owner per year, every year.
Multiply those numbers out over a few hundred dermatologists (although there are thousands around the world) and you get some staggering numbers.
It's a massive opportunity which has the potential to make Verisante a $1 billion company as the Aura spreads across high-demand markets in Canada, Europe, and the United States.
On top of that, it's important to keep in mind that's just with melanoma. Verisante's technology has been proven to successfully identify many different types of cancers. Early trials have shown its effectiveness in identifying lung, cervical, and colon cancer.
Melanoma is just where Verisante's technology has had most of the research and testing geared towards. Once you add in potential opportunities in the other cancers, Verisante's potential is exponentially higher over the long run.
Nearing the Finish Line
Verisante seems to have it all. It's better, cheaper, and potentially very profitable. But the key with any investment in medical technology is completing the regulatory approval processes.
Verisante is aiming at completing the regularity approval process in a faster, less-costly way.
First, most of the expensive and time-consuming research is already completed. The Aura device has been in development for about 10 years. And it already has one six-year study completed.
Now Verisante is in the final stages of approval with Canadian medical authorities. Final approval is expected to be made by the end of 2011.
After that, Verisante has already started the European approval process. It expects to the "CE Mark" (the symbol of European approval) to be granted as early as the end of 2011.
If and when this is approved, Verisante has instant access to markets in the European Union, South Africa, and Australia.
Finally, with European and Canadian approval in hand, its' going to then move to the United States. It needs more studies for U.S. approval, but like many other drugs and medical devices, it's a lot more likely to get approval in the United States after Canada and Europe give the official thumbs up.
A Big Winner in the Making
Verisante Technology (TSX-V:VRS or OTCQX:VRSEF) is in position to have an exciting few months ahead as the story unfolds and even more great years beyond that.
It has all the elements of a giant med-tech success story.
It has superior, proven technology.
It has years of costly and time-consuming research behind it.
It's very near to final regulatory approval in Canada.
It has shown the potential to save a lot of lives too.
On top of all that, Verisante was recently able to attract an addition $5 million capital infusion in a market where med-tech and biotech aren't getting very much venture capital.
Perhaps most importantly, Verisante has huge growth potential. At a mere $35 market cap, the upside is tremendous. Remember, its closest competitor, MELAScience, had a market value of about $200 million just in anticipation it would be successful. And after it got rejected by the FDA, it still has a $90 million market value.
That's the kind of potential here where once the Aura is approved; Verisante is on its way to being worth $1 billion.
Head over to Verisante.com to see for yourself.
Andrew Mickey
Chief Investment Strategist, Q1 Publishing
Disclosure: The editor does not own shares and is not paid by any of the companies mentioned for distribution of this report. It is, however, an open recommendation in Q1 Publishing's President's List premium research service.
If you like ideas and research like this, the President's List is a premium investment research focused on the maximum risk-reward opportunities available anywhere in the world. You can learn more about a no-risk trial offer here. Legal Disclaimer : The information contained on this e-mail and in other Q1 Publishing communications is intended for general information purposes only. Q1 Publishing has not taken into account the specific investment objectives of any particular investor. You should always seek the counsel of a professional financial advisor before purchasing or selling stock. Directors, employees and outside contributors to Q1 Publishing may hold substantial positions in the recommended securities and may increase or decrease such positions without notice. We believe the sources of information to be reliable but Q1 Publishing does not guarantee the accuracy or completeness of the information provided on this website or in other Q1 communications, and expressly disclaims liability for any errors or omissions that may be contained in the information
Investorideas.com disclaimer and disclosure - the following news is a paid news release distribution (one thousand for 2 releases) Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
The published report by Q1 Publishing is the property of Q1 Publishing and is not the opinion of Investorideas.com
Monday, May 09, 2011
Investorideas.com invites investors trading gold and mining stocks to become a Facebook.com Fan and receive a free mining stocks directory
Investors can also Register for free online mining conference, Follow the Money in Mining and Metals
The stock directories are just one of the tools to help investors in the mining sector. This month, Investorideas.com and Smallcapvoice.com are hosting the online mining conference, Follow the Money in Mining and Metals, May 25th and 26. The online conference is free to investors with login registration.
Free Investor Sign-Up -http://www.smallcapvoice.com/ii_scv/investor-signup.html
Facebook Badge
Look for us on Facebook.com -
Investorideas.com- Investing ideas that can change the world
FACEBOOK BADGE
Investorideas.com- Investing ideas that can change the world
Promote Your Page TooAbout our mining stocks directory:
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!
More mining stocks research - free online investor conference
Follow the Money in Mining and Metals, May 25th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
About our Mining Portals:
http://www.gold-miningstocks.com/ and http://www.miningsectorstocks.com/ are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1300 mining stocks.
Become an Investor Ideas Member
Investor Ideas members get access to the most comprehensive stock directories online with 24/7 login access to water stocks, renewable energy stocks and more. Learn more: http://www.investorideas.com/membership/
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Offer limited to first 25 new fans
Mining Stocks; Lucky Strike (TSX-V:LKY) Terminates Changyun Project, Clarifies Changyun and Nkak Coal Project Disclosures
VANCOUVER, BRITISH COLUMBIA, CANADA - May 9, 2011 (Investorideas.com Newswire) - Lucky Strike Resources Ltd. (TSX-V:LKY) (the "Company" or "Lucky Strike"), advises that it has terminated the Letter of Intent to acquire an interest in the Changyun project as a result of the Company's inability to resolve certain due diligence issues, negotiate a formal definitive agreement, secure financial and technical control of the project, and obtain sufficient and acceptable security in order to advance further funding for the Changyun project. Today, May 6th, the Company formally advised Cheung Wan (Groups) Energy Development Limited ("Cheung Wan") of the termination of the Company's rights under the Letter of Intent announced on October 29, 2010, given the difficulties to date and the requirement for the technical report whi! ch would not be fulfilled in the short term without the cooperation of Cheung Wan. Consequently, Lucky Strike wishes to focus on more favorable projects.
As a result of a review by the British Columbia Securities Commission, the Company is issuing the following news release to clarify disclosure regarding the Changyun coal project in the People's Republic ofChina
, and the NKAK coal and transportation project in Mongolia.
Clarification of Changyun Disclosure
The July 10, 2010, report titled 'Technical Report on the Changyun Coal Mine', filed on SEDAR on December 3, 2010 (the Report), is not compliant with National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101) as stated in the Summary (paragraph 4) and Section 5.1 (paragraph 1) of the Report: 'This report is not compliant with NI 43-101 and SEC Guide No 7.' The Report was based on technical work carried out by the 113th Geological Team of Guizhou Province and reviewed by the 105th Geological Team of the Guizhou Province in China. This technical work follows the Chinese resource estimation standards which differ from the NI 43-101 standards and, Chinese data and estimates require verification and conversion to NI 43-101 definitions before they can be relied on to conduct and disclose any economic analysis as defined in NI 43-101.
It was the intention of Lucky Strike to complete the Definitive Agreement and carry out a drill and study program to provide a NI 43-101 compliant report as announced in the Company's news release dated December 6th, 2010, about retaining Wardrop to perform the technical services. Without a Definitive Agreement signed by both parties, a lack of access to the property prevents the implementation of the drilling program and subsequent completion of a NI 43-101 Technical Report.
The preliminary assessment (PA) presented in the Report is preliminary in nature. It used non-compliant 'inferred mineral resources' in the Report, which the company did not verify as current coal resources, and which are not suitable for use in a PA as defined in NI 43-101. If validated, current inferred resources are too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that a PA using inferred resources will be realized.
The Company retracts the inferred resource and PA in the Report, on its previous website, in investor materials, and in an 'Emerging Growth Stocks' reprint on its previous website.
Former management made the first deposit amount of $150,000 on August 9, 2010, as announced on the August 10, 2010, news release. A second deposit of US $150,000 was announced on the October 29, 2010, news release. The total deposit today is $300,000.
Lucky Strike has sought legal advice to have its $300,000 refundable deposit returned and is considering the cost of pursuing the deposit funds.
No finder's fees pursuant to the signing of the 80% LOI were paid out.
The NKAK Project, Mongolia
The company clarifies that indications of 'near-term cash flow' and 'coal revenue' in its Stockwatch eblast and in Infostock dated April 27, 2011, do not pertain to the NKAK Property, which is an exploration stage property without a defined resource, and where the quality and quantity of coal is yet to be determined. A reconnaissance survey in July 2010 resulted only in the delineation of coal occurrences, and this data is not sufficient to complete a NI 43-101 technical report. The delineation of coal occurrences should not be relied on until they are independently verified and supported by a technical report.
In the event the company receives a coal resource estimate that is a material change to its affairs, it will promptly disclose the results and file a supporting technical report as required by NI 43-101.
Coal Transportation
The company also clarifies information about transport contracts for one million tonnes coal/year indicated by the Stockwatch eblast and Infostock. Before additional exploration determines suitable quality and quantities of coal at NKAK and a relevant economic analysis is prepared, there can be no certainty that any quantities of coal suitable for transport may be available on the NKAK property.
Pursuant to the Letter Agreement announced on April 27, 2011, the Representative has agreed to use its reasonable commercial efforts to secure and assign transportation contracts to the JV Company for the transportation of a minimum of one million tonnes of coal per annum ('tpy') from Mongolia to China within the first three years of operation. The Representative's affiliate company holds a transportation licence and contract and has transported 500,000 tonnes of coking coal from Tavan Tolgoi to Tsagaan Had, a reloading station, through the Gashuun Suhait Mongolian-Chinese border to the finaldestination of Gants Mod in China. The Company anticipates that these contracts may provide revenue while it completes exploration on the property and, if successful, would provide means to deliver the coal directly to the market.
Financial Terms
In order to acquire up to a 75% ownership interest in the JV Company, Lucky Strike is required to: (a) make a non-refundable payment of US $300,000 to the Representative upon execution of the Letter Agreement; (b) make US $600,000 in cash payments to the Representative over a three year period of which US$500,000 is payable upon receipt of TSXV approval, US$50,000 is payable on the first year anniversary of the approval date and US$25,000 is payable on both the second and third anniversary of the approval date; and (c) complete a minimum of US$8 million in exploration and development expenditures over a three year period of which US$1 million to be spent by the first year anniversary of the approval date, US$2 million to be spent by the second year anniversary of the approval date and US$5 million to be spent by the third year anniversary of the approval date. The acquisition is subject to completion of legal and technical due diligence and acceptance by the TSX Venture Exc! hange.
Finder's fees may be paid, and will be in accordance with TSX Venture Exchange policies, and is subject to the approval of the regulatory authorities.
Property Review
Lucky Strike signed a letter agreement (the 'Letter Agreement') with a private Mongolian company (the 'Representative') that represents the owner of two exploration licenses covering an area of 8,736 hectares 3 km west of the Olonbulag coking coal deposits in the aimag of Hovd in southwest Mongolia. The properties are known as the Nariin Khargait and Ar Khadnii Ovoo coal properties (the 'NKAK Properties'). Under the terms of the Letter Agreement, the NKAK Properties will be assigned into a joint venture company ('the JV Company'). Lucky Strike can earn a 75% ownership interest in the JV Company.
Edwin Ullmer, P. Geo., a Qualified Person as defined by National Instruments 43-101, has read and approved the technical information in this news release.
Christian Derosier, P. Geo., M.Sc., D.Sc., a Qualified Person as defined by National Instruments 43-101, has read and approved the technical information in this news release.
Updates on the Projects
The Company has elected to terminate its interest in acquiring the Changyun project as it has not been able to come to agreeable terms in a definitive agreement with the Vendor. Therefore, Lucky Strike is now focusing on completing the due diligence on the coal transportation and NKAK exploration project in Mongolia. Furthermore, the Company is concurrently continuing to investigate other potential property acquisitions and will provide further updates as and when the Company enters into any agreements with respect to same.
On behalf of Management,
Lucky Strike Resources Ltd.
'Cathy Fong'
Cathy Fong, Chairman & CEO, Director
Further Information
For further information relating to the Company or this release please visit the Lucky Strike Resource website at www.luckstrikeresources or contact Investor Relations at 604-360-8199 www.luckystrikeresources.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the UnitedStates Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time with the Toronto Venture Exchange, the British Columbia Securities Commission and the US Securities and Exchange C! ommission.
The above forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions, which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) the risk that the Company does not execute its business plan, (2) inability to finance operations and growth, (3) inability to obtain all necessary environmental and regulatory approvals, and (4) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.
Twitter: www.twitter.com/luckystrike
Facebook: www.facebook.com/luckystrikepr
VANCOUVER, BRITISH COLUMBIA, CANADA - May 9, 2011 (Investorideas.com Newswire) - Lucky Strike Resources Ltd. (TSX-V:LKY) (the "Company" or "Lucky Strike"), advises that it has terminated the Letter of Intent to acquire an interest in the Changyun project as a result of the Company's inability to resolve certain due diligence issues, negotiate a formal definitive agreement, secure financial and technical control of the project, and obtain sufficient and acceptable security in order to advance further funding for the Changyun project. Today, May 6th, the Company formally advised Cheung Wan (Groups) Energy Development Limited ("Cheung Wan") of the termination of the Company's rights under the Letter of Intent announced on October 29, 2010, given the difficulties to date and the requirement for the technical report whi! ch would not be fulfilled in the short term without the cooperation of Cheung Wan. Consequently, Lucky Strike wishes to focus on more favorable projects.
As a result of a review by the British Columbia Securities Commission, the Company is issuing the following news release to clarify disclosure regarding the Changyun coal project in the People's Republic of
Clarification of Changyun Disclosure
The July 10, 2010, report titled 'Technical Report on the Changyun Coal Mine', filed on SEDAR on December 3, 2010 (the Report), is not compliant with National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101) as stated in the Summary (paragraph 4) and Section 5.1 (paragraph 1) of the Report: 'This report is not compliant with NI 43-101 and SEC Guide No 7.' The Report was based on technical work carried out by the 113th Geological Team of Guizhou Province and reviewed by the 105th Geological Team of the Guizhou Province in China. This technical work follows the Chinese resource estimation standards which differ from the NI 43-101 standards and, Chinese data and estimates require verification and conversion to NI 43-101 definitions before they can be relied on to conduct and disclose any economic analysis as defined in NI 43-101.
It was the intention of Lucky Strike to complete the Definitive Agreement and carry out a drill and study program to provide a NI 43-101 compliant report as announced in the Company's news release dated December 6th, 2010, about retaining Wardrop to perform the technical services. Without a Definitive Agreement signed by both parties, a lack of access to the property prevents the implementation of the drilling program and subsequent completion of a NI 43-101 Technical Report.
The preliminary assessment (PA) presented in the Report is preliminary in nature. It used non-compliant 'inferred mineral resources' in the Report, which the company did not verify as current coal resources, and which are not suitable for use in a PA as defined in NI 43-101. If validated, current inferred resources are too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that a PA using inferred resources will be realized.
The Company retracts the inferred resource and PA in the Report, on its previous website, in investor materials, and in an 'Emerging Growth Stocks' reprint on its previous website.
Former management made the first deposit amount of $150,000 on August 9, 2010, as announced on the August 10, 2010, news release. A second deposit of US $150,000 was announced on the October 29, 2010, news release. The total deposit today is $300,000.
Lucky Strike has sought legal advice to have its $300,000 refundable deposit returned and is considering the cost of pursuing the deposit funds.
No finder's fees pursuant to the signing of the 80% LOI were paid out.
The NKAK Project, Mongolia
The company clarifies that indications of 'near-term cash flow' and 'coal revenue' in its Stockwatch eblast and in Infostock dated April 27, 2011, do not pertain to the NKAK Property, which is an exploration stage property without a defined resource, and where the quality and quantity of coal is yet to be determined. A reconnaissance survey in July 2010 resulted only in the delineation of coal occurrences, and this data is not sufficient to complete a NI 43-101 technical report. The delineation of coal occurrences should not be relied on until they are independently verified and supported by a technical report.
In the event the company receives a coal resource estimate that is a material change to its affairs, it will promptly disclose the results and file a supporting technical report as required by NI 43-101.
Coal Transportation
The company also clarifies information about transport contracts for one million tonnes coal/year indicated by the Stockwatch eblast and Infostock. Before additional exploration determines suitable quality and quantities of coal at NKAK and a relevant economic analysis is prepared, there can be no certainty that any quantities of coal suitable for transport may be available on the NKAK property.
Pursuant to the Letter Agreement announced on April 27, 2011, the Representative has agreed to use its reasonable commercial efforts to secure and assign transportation contracts to the JV Company for the transportation of a minimum of one million tonnes of coal per annum ('tpy') from Mongolia to China within the first three years of operation. The Representative's affiliate company holds a transportation licence and contract and has transported 500,000 tonnes of coking coal from Tavan Tolgoi to Tsagaan Had, a reloading station, through the Gashuun Suhait Mongolian-Chinese border to the final
Financial Terms
In order to acquire up to a 75% ownership interest in the JV Company, Lucky Strike is required to: (a) make a non-refundable payment of US $300,000 to the Representative upon execution of the Letter Agreement; (b) make US $600,000 in cash payments to the Representative over a three year period of which US$500,000 is payable upon receipt of TSXV approval, US$50,000 is payable on the first year anniversary of the approval date and US$25,000 is payable on both the second and third anniversary of the approval date; and (c) complete a minimum of US$8 million in exploration and development expenditures over a three year period of which US$1 million to be spent by the first year anniversary of the approval date, US$2 million to be spent by the second year anniversary of the approval date and US$5 million to be spent by the third year anniversary of the approval date. The acquisition is subject to completion of legal and technical due diligence and acceptance by the TSX Venture Exc! hange.
Finder's fees may be paid, and will be in accordance with TSX Venture Exchange policies, and is subject to the approval of the regulatory authorities.
Property Review
Lucky Strike signed a letter agreement (the 'Letter Agreement') with a private Mongolian company (the 'Representative') that represents the owner of two exploration licenses covering an area of 8,736 hectares 3 km west of the Olonbulag coking coal deposits in the aimag of Hovd in southwest Mongolia. The properties are known as the Nariin Khargait and Ar Khadnii Ovoo coal properties (the 'NKAK Properties'). Under the terms of the Letter Agreement, the NKAK Properties will be assigned into a joint venture company ('the JV Company'). Lucky Strike can earn a 75% ownership interest in the JV Company.
Edwin Ullmer, P. Geo., a Qualified Person as defined by National Instruments 43-101, has read and approved the technical information in this news release.
Christian Derosier, P. Geo., M.Sc., D.Sc., a Qualified Person as defined by National Instruments 43-101, has read and approved the technical information in this news release.
Updates on the Projects
The Company has elected to terminate its interest in acquiring the Changyun project as it has not been able to come to agreeable terms in a definitive agreement with the Vendor. Therefore, Lucky Strike is now focusing on completing the due diligence on the coal transportation and NKAK exploration project in Mongolia. Furthermore, the Company is concurrently continuing to investigate other potential property acquisitions and will provide further updates as and when the Company enters into any agreements with respect to same.
On behalf of Management,
Lucky Strike Resources Ltd.
'Cathy Fong'
Cathy Fong, Chairman & CEO, Director
Further Information
For further information relating to the Company or this release please visit the Lucky Strike Resource website at www.luckstrikeresources or contact Investor Relations at 604-360-8199 www.luckystrikeresources.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the United
The above forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions, which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) the risk that the Company does not execute its business plan, (2) inability to finance operations and growth, (3) inability to obtain all necessary environmental and regulatory approvals, and (4) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.
Twitter: www.twitter.com/luckystrike
Facebook: www.facebook.com/luckystrikepr
Electric Car Stock News Alert; EVCARCO, Inc. (OTCBB: EVCA) Announces an Expressed Interest in Acquiring Mitsubishi Franchises
FT. WORTH, TX � May 9, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) (OTCQB:EVCA) announced today an expressed interest in acquiring Mitsubishi Franchises due to the leadership position Mitsubishi Motor Corporation has taken in the electric vehicle (EV) market and its efforts to reduce environmental impact.
Scott O'Neal, Co-Founder & COO of EVCARCO, stated, "Our acquisition plan announced publicly on April 14, 2011 was to evaluate and acquire dealerships and align the Company with major manufacturers that produce vehicles consumers want to drive. One of the manufacturers we are considering is Mitsubishi and its electric vehicle, MiEV, as seen in the Dallas and Fort Worth Auto Shows."
The i, or MiEV, is powered by Mitsubishi's innovative Electric Vehicle (MiEV) technology. The electric motor can go from zero to 60 in under 9 seconds. The rear-wheel drive vehicle has a 49kW (66 bhp) AC synchronous electric motor; an 88 cell, 330 V lithium-ion battery pack for peak storage of 16 kWh; an onboard charger and a single fixed reduction gear transmission. The electric motor is capable of producing a peak torque of 145 lb. ft. almost instantaneously when accelerating from a standstill. It can reach up to 80 miles per hour.
More information about Mitsubishi MiEV: http://i.mitsubishicars.com/?ic=T_homepg-hero_100005_04012011
The Company is working through THE Search Firm to facilitate the acquisitions of current Mitsubishi Franchises through Buy/Sell agreements. Current Mitsubishi Dealers interested in learning more should contact Jason Poucher, THE Search Firm at 866-441-5627.
THE Search Firm (www.automotivebuysell.com) was established to provide executive level consulting to the automotive industry. The company has since evolved into one of the leading automotive consulting firms in the nation by providing expertise in both the recruiting and placement arena as well as the brokerage of automotive dealerships.
For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO -- Future Driven®
This Press Release contains certain forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Contact:
Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax
FT. WORTH, TX � May 9, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) (OTCQB:EVCA) announced today an expressed interest in acquiring Mitsubishi Franchises due to the leadership position Mitsubishi Motor Corporation has taken in the electric vehicle (EV) market and its efforts to reduce environmental impact.
Scott O'Neal, Co-Founder & COO of EVCARCO, stated, "Our acquisition plan announced publicly on April 14, 2011 was to evaluate and acquire dealerships and align the Company with major manufacturers that produce vehicles consumers want to drive. One of the manufacturers we are considering is Mitsubishi and its electric vehicle, MiEV, as seen in the Dallas and Fort Worth Auto Shows."
The i, or MiEV, is powered by Mitsubishi's innovative Electric Vehicle (MiEV) technology. The electric motor can go from zero to 60 in under 9 seconds. The rear-wheel drive vehicle has a 49kW (66 bhp) AC synchronous electric motor; an 88 cell, 330 V lithium-ion battery pack for peak storage of 16 kWh; an onboard charger and a single fixed reduction gear transmission. The electric motor is capable of producing a peak torque of 145 lb. ft. almost instantaneously when accelerating from a standstill. It can reach up to 80 miles per hour.
More information about Mitsubishi MiEV: http://i.mitsubishicars.com/?ic=T_homepg-hero_100005_04012011
The Company is working through THE Search Firm to facilitate the acquisitions of current Mitsubishi Franchises through Buy/Sell agreements. Current Mitsubishi Dealers interested in learning more should contact Jason Poucher, THE Search Firm at 866-441-5627.
THE Search Firm (www.automotivebuysell.com) was established to provide executive level consulting to the automotive industry. The company has since evolved into one of the leading automotive consulting firms in the nation by providing expertise in both the recruiting and placement arena as well as the brokerage of automotive dealerships.
For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO -- Future Driven®
This Press Release contains certain forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Contact:
Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax
Visit the EVCA showcase profile at Investorideas.com
Request News and Info on EVCA
Disclosure, Disclaimer/ EVCA is a paid advertising client on Investorideas.com and our renewable energy portals (500,000 144 shares).
Request News and Info on EVCA
Disclosure, Disclaimer/ EVCA is a paid advertising client on Investorideas.com and our renewable energy portals (500,000 144 shares).
Biotech/Biodefense Stock News; Aethlon Medical (OTCBB: AEMD) Discloses FDA Meeting Request and Proposed Expansion of U.S. Treatment Indications to Include Hepatitis C Virus (HCV)
SAN DIEGO - May 9, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) announces that it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States. As part of these discussions, Aethlon management will present FDA officials with new clinical data that supports the safety of the Hemopurifier® and demonstrates the capability of the medical device to reduce viral load in individuals infected with the hepatitis C virus (HCV). Based on the data to be presented, Aethlon will request permission to expand the target treatment indications of the Hemopurifier® to include HCV in the U.S. At present, the treatment indication underlying the Aethlon IDE is solely directed toward the use of the Hemopurifier® as a countermeasure against bioterror and pandemic threats.
"Since submitting our IDE, we have expanded our collection of human safety data, which has also provided insight that our Hemopurifier® can have a substantial effect in reducing viral load in HCV-infected patients even in the absence of antiviral drugs," stated Jim Joyce, Chairman and CEO of Aethlon Medical. "These results combined with the emergence of a remarkable clinical validation for therapeutic filtration in HCV care provide a compelling basis for an FDA meeting to discuss and advance a potential clinical strategy to treat HCV-infected individuals in the United States."
The meeting with the FDA will provide a collaborative opportunity for Aethlon management to interact directly with Agency officials and to obtain guidance and input on advancing both its HCV and Medical Countermeasure indications in the U.S. Aethlon anticipates a meeting with FDA officials will likely occur in mid-summer.
The Company believes a significant and enduring opportunity exists for the Hemopurifier® as an adjunct to improve the benefit of current, forthcoming and future iterations of standard-of-care drug therapy (SOC) by accelerating viral load depletion in the first few days of HCV-SOC. The clinical validation for therapeutic filtration of HCV has been established by the VRAD system developed and marketed by Asahi Kasei Kuraray Medical in Japan. The early administration of VRAD in combination with HCV-SOC achieved 71.4% sustained virologic response rates (SVR) in HCV patients who previously failed HCV-SOC. These results were achieved through a once daily administration of VRAD for three consecutive days at the outset of SOC therapy. The average viral load reduction during each treatment period, which averaged 3 1/4 hours in duration, was 26.1%. In comparison, the Aethlon Hemopurifier® has demonstrated average viral load reductions of 64% during similar treatment timeframes in the absence of any drug therapy benefit. Aethlon is now actively advancing an adjunct study to demonstrate the ability of the Hemopurifier® to accelerate early viral load depletion in patients who initiate HCV-SOC. The study is being conducted at the Medanta Medicity Institute in Delhi, India.
The Hemopurifier® is also uniquely suited to treat HCV-infected End-stage renal disease (ESRD) patients, whose condition limits their ability to be treated with HCV-SOC. The incidence of HCV infection in ESRD patients is approximately 100-1000 times higher than that in the general population. Recent studies have clearly shown that HCV-infected ESRD patients on maintenance dialysis are at increased risk of liver-related mortality. A significant proportion develops chronic hepatitis, cirrhosis, and even hepatocellular carcinoma. Overall, chronic HCV patients on hemodialysis bear an increased risk of liver-related morbidity and mortality, either during dialysis or after renal transplantation. Interferon (IFN) therapy is modestly effective for the treatment of HCV infection in ESRD patients but is not recommended after renal transplantation due to the risk of acute graft rejection. Ribavirin is considered contraindicated for the treatment of ESRD patients with chronic hepatitis C because of the risk of life-threatening hemolytic anemia. A major advantage in treating HCV-infected ESRD patients with the Hemopurifier® is that the device adds no drug toxicity or interaction concerns and can be included in series with a patient's dialysis cartridge, thus adding no treatment burden beyond the patient's pre-established dialysis treatment schedule.
Aethlon further disclosed that it will begin discussions with the FDA on the regulatory requirements to obtain an Emergency Use Authorization (EUA) for the Hemopurifier® as a broad-spectrum countermeasure against untreatable viral threats that emerge naturally or are released by man as an agent of bioterrorism. The Project BioShield Act of 2004 permits the FDA Commissioner to authorize the use of an unapproved medical product during a declared emergency involving a heightened risk of attack on the public or U.S. military forces, or a significant potential to affect national security. The EUA authority allows the FDA Commissioner to strengthen the public health protections against biological, chemical, radiological and nuclear agents that may be used to attack the American people or the U.S. armed forces. The FDA Commissioner may allow medical countermeasures to be used in an emergency to diagnose, treat or prevent serious or life-threatening diseases or conditions caused by such agents, when there are no adequate, approved and available alternatives.
Aethlon believes the Hemopurifier®, which is the sole antiviral strategy to address drug and vaccine resistant viral pathogens, is well positioned to meet the U.S. government's urgent need for innovative new medical countermeasures that can be deployed during national health emergencies.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
SAN DIEGO - May 9, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) announces that it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States. As part of these discussions, Aethlon management will present FDA officials with new clinical data that supports the safety of the Hemopurifier® and demonstrates the capability of the medical device to reduce viral load in individuals infected with the hepatitis C virus (HCV). Based on the data to be presented, Aethlon will request permission to expand the target treatment indications of the Hemopurifier® to include HCV in the U.S. At present, the treatment indication underlying the Aethlon IDE is solely directed toward the use of the Hemopurifier® as a countermeasure against bioterror and pandemic threats.
"Since submitting our IDE, we have expanded our collection of human safety data, which has also provided insight that our Hemopurifier® can have a substantial effect in reducing viral load in HCV-infected patients even in the absence of antiviral drugs," stated Jim Joyce, Chairman and CEO of Aethlon Medical. "These results combined with the emergence of a remarkable clinical validation for therapeutic filtration in HCV care provide a compelling basis for an FDA meeting to discuss and advance a potential clinical strategy to treat HCV-infected individuals in the United States."
The meeting with the FDA will provide a collaborative opportunity for Aethlon management to interact directly with Agency officials and to obtain guidance and input on advancing both its HCV and Medical Countermeasure indications in the U.S. Aethlon anticipates a meeting with FDA officials will likely occur in mid-summer.
The Company believes a significant and enduring opportunity exists for the Hemopurifier® as an adjunct to improve the benefit of current, forthcoming and future iterations of standard-of-care drug therapy (SOC) by accelerating viral load depletion in the first few days of HCV-SOC. The clinical validation for therapeutic filtration of HCV has been established by the VRAD system developed and marketed by Asahi Kasei Kuraray Medical in Japan. The early administration of VRAD in combination with HCV-SOC achieved 71.4% sustained virologic response rates (SVR) in HCV patients who previously failed HCV-SOC. These results were achieved through a once daily administration of VRAD for three consecutive days at the outset of SOC therapy. The average viral load reduction during each treatment period, which averaged 3 1/4 hours in duration, was 26.1%. In comparison, the Aethlon Hemopurifier® has demonstrated average viral load reductions of 64% during similar treatment timeframes in the absence of any drug therapy benefit. Aethlon is now actively advancing an adjunct study to demonstrate the ability of the Hemopurifier® to accelerate early viral load depletion in patients who initiate HCV-SOC. The study is being conducted at the Medanta Medicity Institute in Delhi, India.
The Hemopurifier® is also uniquely suited to treat HCV-infected End-stage renal disease (ESRD) patients, whose condition limits their ability to be treated with HCV-SOC. The incidence of HCV infection in ESRD patients is approximately 100-1000 times higher than that in the general population. Recent studies have clearly shown that HCV-infected ESRD patients on maintenance dialysis are at increased risk of liver-related mortality. A significant proportion develops chronic hepatitis, cirrhosis, and even hepatocellular carcinoma. Overall, chronic HCV patients on hemodialysis bear an increased risk of liver-related morbidity and mortality, either during dialysis or after renal transplantation. Interferon (IFN) therapy is modestly effective for the treatment of HCV infection in ESRD patients but is not recommended after renal transplantation due to the risk of acute graft rejection. Ribavirin is considered contraindicated for the treatment of ESRD patients with chronic hepatitis C because of the risk of life-threatening hemolytic anemia. A major advantage in treating HCV-infected ESRD patients with the Hemopurifier® is that the device adds no drug toxicity or interaction concerns and can be included in series with a patient's dialysis cartridge, thus adding no treatment burden beyond the patient's pre-established dialysis treatment schedule.
Aethlon further disclosed that it will begin discussions with the FDA on the regulatory requirements to obtain an Emergency Use Authorization (EUA) for the Hemopurifier® as a broad-spectrum countermeasure against untreatable viral threats that emerge naturally or are released by man as an agent of bioterrorism. The Project BioShield Act of 2004 permits the FDA Commissioner to authorize the use of an unapproved medical product during a declared emergency involving a heightened risk of attack on the public or U.S. military forces, or a significant potential to affect national security. The EUA authority allows the FDA Commissioner to strengthen the public health protections against biological, chemical, radiological and nuclear agents that may be used to attack the American people or the U.S. armed forces. The FDA Commissioner may allow medical countermeasures to be used in an emergency to diagnose, treat or prevent serious or life-threatening diseases or conditions caused by such agents, when there are no adequate, approved and available alternatives.
Aethlon believes the Hemopurifier®, which is the sole antiviral strategy to address drug and vaccine resistant viral pathogens, is well positioned to meet the U.S. government's urgent need for innovative new medical countermeasures that can be deployed during national health emergencies.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
- Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
- Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
- Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
- Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011
Effective March 15, 2011
Sunday, May 08, 2011
Join Investorideas.com on Facebook- become a Fan- get our mining stocks directory free- a $29.95 Value
FACEBOOK BADGE
Investorideas.com- Investing ideas that can change the world
Promote Your Page Too
Investorideas.com invites its ubscribers to join us on Facebook.coom and the first 25 fans get a free mining stocks directory for free emailed to them in PDF format ( $29.95 value)
- Just email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Investor Ideas members get access to the most comprehensive cleantech stock directories online with 24/7 login access to water stocks, renewable energy stocks and more.
Learn more: http://www.investorideas.com/membership/
800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
FACEBOOK BADGE
Promote Your Page Too
Investorideas.com invites its ubscribers to join us on Facebook.coom and the first 25 fans get a free mining stocks directory for free emailed to them in PDF format ( $29.95 value)
- Just email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Investor Ideas members get access to the most comprehensive cleantech stock directories online with 24/7 login access to water stocks, renewable energy stocks and more.
Learn more: http://www.investorideas.com/membership/
800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Friday, May 06, 2011
Investing Ideas that can Change the World
Tools for Investing in Water, Renewable Energy, Agriculture, Technology
and Biotech for Investors that want to invest in Change
POINT ROBERTS, Wash., May 6 2011 - www.InvestorIdeas.com ( Investor
Ideas) , a leader in investor research in sectors including water and renewable
energy has recently added new stock directories for independent investors that
use online resources to make their own investment decisions.
In a changing world politically, economically and socially, Investor Ideas
empowers individual investors from around the world to research and invest in
sectors that matter most to them .
Investor Ideas has created the most comprehensive stock directories available to
individual investors , including water stocks, renewable energy stocks, biotech
stocks, agriculture stocks, nanotech stocks, tech stocks , defense stocks, mining
stocks, oil and gas stocks and natural gas stocks as a potential clean energy
source.
As social networking has played a key role in changing the face of the world
politically, investors can also take the leap and invest in Social Networking
stocks.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy
Stocks Directory in PDF format includes over 1300 stocks on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges . The directory features hyperlinks to stocks symbol(s),
company’s URL and company’s description. The directory includes info and links
on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency
Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen
Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green
Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure
Stocks. For investors following green stocks, this is the most comprehensive
global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory
in PDF format lists over 1100 publicly traded mining companies. Mining and
metals investors can research gold and mining stocks with the mining stocks
directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks,
Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading Stock Exchanges. directory features
hyperlinks to stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly
traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
comprehensive directory gives investors a full range and choice of micro cap
to large cap stocks in the energy sector. The directory in PDF format, features
hyperlinks to over 600 stocks symbol(s), company's URL and company's
description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed
on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China
and other leading global Stock Exchanges . The comprehensive directory gives
investors a full range and choice of micro cap to large cap stocks in the coal
sector, including clean coal and coking coal stocks. The directory in PDF format,
features hyperlinks to coal stocks symbol(s), company's URL and company's
description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks
Directory features publicly traded defense stocks listed on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges. The directory, in PDF format, includes Homeland Security
Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security Stocks,
Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks
symbol(s), company's URL and company's description. For defense stocks
followers, this is one of the most comprehensive global stock directories available
to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water
stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The stock directory features
water stocks ranging from desalination companies to bottled water stocks, to
infrastructure, water treatment and technology as well as other sub sectors. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description. For investors following water stocks this is one of the
most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly
traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small
cap, micro cap as well as large cap NYSE listed stocks for review. For green
investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to
stocks symbol(s), company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma
and Life Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading global Stock Exchanges . The directory
covers all sub sectors of biotech including nanotech, biodefense and stem cell
stocks. The directory includes small cap, micro cap as well as large cap NYSE
listed stocks for investors The comprehensive global directory in PDF format
provides a great research tool for biotechnology investors with hyperlinks to
stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small cap,
micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks
included range from LNG, Coal Bed Methane to exploration and producers in
the sector. The directory in PDF format, features hyperlinks to stocks symbol(s),
company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory
of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock
Exchanges. Directory includes nanotech- biotech companies, nanotech water
and renewable energy companies and more. Directory features company
description, stock symbol and hyperlink to recent quote and info, link to website
and more.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector
investing content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as
an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we
offer no guarantees as to the accuracy of information presented. All Information relating to featured
companies is sourced from public documents and/ or the company and is not the opinion of our web sites.
This site is currently compensated by featured companies, news submissions and online advertising.
www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue
partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Tools for Investing in Water, Renewable Energy, Agriculture, Technology
and Biotech for Investors that want to invest in Change
POINT ROBERTS, Wash., May 6 2011 - www.InvestorIdeas.com ( Investor
Ideas) , a leader in investor research in sectors including water and renewable
energy has recently added new stock directories for independent investors that
use online resources to make their own investment decisions.
In a changing world politically, economically and socially, Investor Ideas
empowers individual investors from around the world to research and invest in
sectors that matter most to them .
Investor Ideas has created the most comprehensive stock directories available to
individual investors , including water stocks, renewable energy stocks, biotech
stocks, agriculture stocks, nanotech stocks, tech stocks , defense stocks, mining
stocks, oil and gas stocks and natural gas stocks as a potential clean energy
source.
As social networking has played a key role in changing the face of the world
politically, investors can also take the leap and invest in Social Networking
stocks.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy
Stocks Directory in PDF format includes over 1300 stocks on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges . The directory features hyperlinks to stocks symbol(s),
company’s URL and company’s description. The directory includes info and links
on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency
Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen
Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green
Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure
Stocks. For investors following green stocks, this is the most comprehensive
global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory
in PDF format lists over 1100 publicly traded mining companies. Mining and
metals investors can research gold and mining stocks with the mining stocks
directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks,
Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading Stock Exchanges. directory features
hyperlinks to stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly
traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
comprehensive directory gives investors a full range and choice of micro cap
to large cap stocks in the energy sector. The directory in PDF format, features
hyperlinks to over 600 stocks symbol(s), company's URL and company's
description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed
on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China
and other leading global Stock Exchanges . The comprehensive directory gives
investors a full range and choice of micro cap to large cap stocks in the coal
sector, including clean coal and coking coal stocks. The directory in PDF format,
features hyperlinks to coal stocks symbol(s), company's URL and company's
description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks
Directory features publicly traded defense stocks listed on the TSX, TSX
Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global
Stock Exchanges. The directory, in PDF format, includes Homeland Security
Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security Stocks,
Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks
symbol(s), company's URL and company's description. For defense stocks
followers, this is one of the most comprehensive global stock directories available
to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water
stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The stock directory features
water stocks ranging from desalination companies to bottled water stocks, to
infrastructure, water treatment and technology as well as other sub sectors. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description. For investors following water stocks this is one of the
most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly
traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The
directory in PDF format, features hyperlinks to stocks symbol(s), company's URL
and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small
cap, micro cap as well as large cap NYSE listed stocks for review. For green
investors looking for opportunities in the fuel cell sector, the comprehensive
global directory in PDF format provides a great research tool with hyperlinks to
stocks symbol(s), company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma
and Life Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX,
NYSE, ASX, AIM and other leading global Stock Exchanges . The directory
covers all sub sectors of biotech including nanotech, biodefense and stem cell
stocks. The directory includes small cap, micro cap as well as large cap NYSE
listed stocks for investors The comprehensive global directory in PDF format
provides a great research tool for biotechnology investors with hyperlinks to
stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas
Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX,
AIM and other leading global Stock Exchanges. The directory includes small cap,
micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks
included range from LNG, Coal Bed Methane to exploration and producers in
the sector. The directory in PDF format, features hyperlinks to stocks symbol(s),
company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory
of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ,
AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock
Exchanges. Directory includes nanotech- biotech companies, nanotech water
and renewable energy companies and more. Directory features company
description, stock symbol and hyperlink to recent quote and info, link to website
and more.
Visit the Investor Ideas membership page to learn more at: http://
www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading
sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector
investing content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as
an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we
offer no guarantees as to the accuracy of information presented. All Information relating to featured
companies is sourced from public documents and/ or the company and is not the opinion of our web sites.
This site is currently compensated by featured companies, news submissions and online advertising.
www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue
partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Security Industry News; Visualant (OTCBB:VSUL) Revenues Jump 100% for Quarter Ending March 31, 2011
SEATTLE - May 6, 2011 (Investorideas.com Defense Newswire) - Summary of Operating Results from Continuing Operations
Security Company Visualant, Inc. (OTCBB: VSUL) reports results for the quarter ending March 31, 2011, as compared to the three months ended March 31, 2010:
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Safe Harbor Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of Visualant, Inc. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)
SEATTLE - May 6, 2011 (Investorideas.com Defense Newswire) - Summary of Operating Results from Continuing Operations
Security Company Visualant, Inc. (OTCBB: VSUL) reports results for the quarter ending March 31, 2011, as compared to the three months ended March 31, 2010:
- Revenues- increased 100% to $2,866,000 from $0.
- Gross profit- increased 100% to $345,000 from $0.
- Net loss was $520,000 as compared to $231,000 for the same quarter in 2010. The loss was due to costs to expand its investor base and annual share issuances to directors.
- Net loss per share was $.01 per share as compared to $.01 per share from the same quarter in 2010.
- Cash flow provided by operations was $928,000 as compared to $(145,000).
- Successfully licensed the Visualant Spectral Pattern Matching (�SPM�) Technology for environmental applications to Javelin LLC.
- Entered into a Letter of Intent to acquire Eagle Technologies, Inc. and commenced due diligence with an anticipated closing during the three months ended June 30, 2011.
- Entered into a consulting agreement with Lance Gima, retired former head of the State of California Forensics' Laboratory to pursue forensic applications of the SPM technology.
- Secured additional institutional funding from Seaside 88 Advisors LLC.
- Continued development of Visualant's SPM technology and demonstrated the technology at leading industry trade shows.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Safe Harbor Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of Visualant, Inc. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.
Contact:Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)
Clean Energy Stock News; Telkonet (OTCQB: TKOI) to Announce First Quarter Results on Monday, May 16, 2011
Milwaukee, WI - May 6, 2011 (Investorideas.com renewable energy green newswire) - Telkonet, Inc. (OTCQB: TKOI), developer of the revolutionary energy management platform named EcoSmart incorporating its patented Recovery Time technology and the leading provider of Internet services for the hospitality industry, announced today that it will hold its first quarter results conference call for analysts and investors on Monday, May 16, 2011 at 4:30 pm ET. Telkonet's Chief Executive Officer, Jason Tienor, and Acting Chief Financial Officer, Gene Mushrush, will host the call. The earnings announcement is scheduled for release shortly before the stock markets open on May 16, 2011.
Date: Monday. May 16, 2011
Time: 4:30 p.m. Eastern (3:30 p.m. Central/1:30 p.m. Pacific)
Access by conference call:
Domestic callers: Dial (877) 317-8230
International callers: Dial (706) 902-2567
Conference ID# 65288763
An audio replay of the call will be available until June 16, 2011 on the Investor Relations page of the Telkonet web site at http://www.telkonet.com/investors.php.
About Telkonet
Telkonet is leading energy management technology provider offering hardware, software and services to Commercial customers throughout the world. The EcoCentral Platform, in conjunction with the EcoSmart Suite of products, provides comprehensive savings, management and reporting of a building's energy consumption. Telkonet's energy management products are installed in properties within the Hospitality, Military, Educational, Healthcare and Residential markets reducing energy consumption, Carbon footprints and eliminating the need for new energy generation. www.telkonet.com
About EthoStream
EthoStream is one of the largest public High-Speed Internet Access (HSIA) providers in the world providing services to more than 2.5 million users monthly across a network of greater than 2,250 locations. EthoStream's EGS line of public-access gateway servers provides real-time monitoring and management of guest-access networks while its 24/7 support center is known for the highest levels of quality and service. With a wide range of product and service offerings and one of the most comprehensive management platforms available for HSIA networks, EthoStream offers solutions for any public access location. www.ethostream.com
All company, brand or product names are registered trademarks or trademarks of their respective holders.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenue due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's Registration Statement and in its Reports on Forms 8-K filed with the Securities and Exchange Commission (SEC).
Twitter: http://twitter.com/telkonet/
Facebook: http://www.facebook.com/pages/Telkonet-Inc/182098285155784
Milwaukee, WI - May 6, 2011 (Investorideas.com renewable energy green newswire) - Telkonet, Inc. (OTCQB: TKOI), developer of the revolutionary energy management platform named EcoSmart incorporating its patented Recovery Time technology and the leading provider of Internet services for the hospitality industry, announced today that it will hold its first quarter results conference call for analysts and investors on Monday, May 16, 2011 at 4:30 pm ET. Telkonet's Chief Executive Officer, Jason Tienor, and Acting Chief Financial Officer, Gene Mushrush, will host the call. The earnings announcement is scheduled for release shortly before the stock markets open on May 16, 2011.
Date: Monday. May 16, 2011
Time: 4:30 p.m. Eastern (3:30 p.m. Central/1:30 p.m. Pacific)
Access by conference call:
Domestic callers: Dial (877) 317-8230
International callers: Dial (706) 902-2567
Conference ID# 65288763
An audio replay of the call will be available until June 16, 2011 on the Investor Relations page of the Telkonet web site at http://www.telkonet.com/investors.php.
About Telkonet
Telkonet is leading energy management technology provider offering hardware, software and services to Commercial customers throughout the world. The EcoCentral Platform, in conjunction with the EcoSmart Suite of products, provides comprehensive savings, management and reporting of a building's energy consumption. Telkonet's energy management products are installed in properties within the Hospitality, Military, Educational, Healthcare and Residential markets reducing energy consumption, Carbon footprints and eliminating the need for new energy generation. www.telkonet.com
About EthoStream
EthoStream is one of the largest public High-Speed Internet Access (HSIA) providers in the world providing services to more than 2.5 million users monthly across a network of greater than 2,250 locations. EthoStream's EGS line of public-access gateway servers provides real-time monitoring and management of guest-access networks while its 24/7 support center is known for the highest levels of quality and service. With a wide range of product and service offerings and one of the most comprehensive management platforms available for HSIA networks, EthoStream offers solutions for any public access location. www.ethostream.com
All company, brand or product names are registered trademarks or trademarks of their respective holders.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenue due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's Registration Statement and in its Reports on Forms 8-K filed with the Securities and Exchange Commission (SEC).
Twitter: http://twitter.com/telkonet/
Facebook: http://www.facebook.com/pages/Telkonet-Inc/182098285155784
Cavan Ventures Inc. (TSX.V: CVN) Announces Crown King Silver Option Of Arizona With Q-Gold Resources Ltd.
Vancouver, British Columbia, CANADA - May 6, 2011 (Investorideas.com Newswire) - Cavan Ventures Inc. (TSX.V-CVN), (http://www.cavanventures.com) (the 'Company') is pleased to announce it has entered into a Mining Option Agreement with Q-Gold Resources Ltd. (TSX.V-QGR) ('Q-Gold') (http://www.qgoldresources.com) whereby Cavan has obtained an 18-month option to earn a 65% participating interest in a prospective Arizona silver joint venture with Q-Gold.
The joint venture will contain Q-Gold's holdings of 3 patented historic silver mines and 22 adjoining U.S. Bureau of Land Management ('BLM') mining claims in the Peck Mining District of Yavapai County, Arizona, totalling 484 acres. The Peck District is famous for its historic high-grade silver production, having produced an 'official' 1,374,000 ounces from 1875 to 1910.
Q-Gold's holdings include the historic 'Black Warrior', 'Isis' and a portion of the 'Silver Prince' silver mines, all of which produced high-grade silver ores during the above period, using primitive mining methods.
As Arizona only became a state in 1912, production records are scarce and difficult to obtain. However, 'Territorial' records show silver production worth $500,000 during the above period from the Black Warrior and the Silver Prince Mines, a portion of the latter which is included in the Agreement. High-grade ore, occurring in ore shoots, went directly to the smelter, with 'milling grade' ore production assaying at 12-16 ounces of silver per ton being crushed and concentrated on site. The mines were closed early in the 20th Century due to the 'Silver Price Depression' and the advent of World War I and have never been re-opened.
By meeting its obligations in U.S. Dollars during the 18-month Option Period, including cash payments to Q-Gold of $275,000, work expenditures of $1,000,000 and issuance of Cavan shares to Q-Gold worth $300,000, Cavan will earn a 65% participating interest in the Joint Venture. During the Option Period, Q-Gold will be Operator for the undertaking.
The known silver mineralization in the Black Warrior and Silver Prince Mines occurs in 'saddle reef' or lenticular deposits in host granites and schists, along vein structures from 50 to 250 feet in width and from 2 to 18 feet in thickness. These occur at depths between 200 and 400 feet. On the property are 5 veins, only two of which have been worked to any extent. Two adits and one shaft were entered and inspected by Q-Gold's geologist, and all contained silver and antimony mineralization. The deposits contain the important silver ore minerals, argentite and pyrargyrite, as well as argentiferous galena and antimonial silver minerals, the latter in their deeper portions. The secondarily leached silver minerals miargyrite, iodargyrite and bromargyrite, were also encountered in the adits.
As noted above, the area contains 3 high grade historic silver mines and a number of BLM claims highly prospective for silver, yet it has never experienced modern mining exploration techniques. Therefore, the venture will initially launch a helicopter-based VTEM / Magnetic airborne geophysical survey which will attempt to delineate anomalies which will indicate potential remaining ore bodies and possible drilling sites within the complex.
Mr. Andrew Mah remarked 'With silver prices at recent record highs, I look forward to initiating modern joint exploration activities this summer with Q-Gold in the historic silver-producing Peck Mining District of Arizona.'
The historical references contained in this release have not been verified by a qualified person under NI 43-101 and therefore cannot be relied on for any purpose. Brian A. Beck, PG a qualified person under NI 43-101 has reviewed and approved the technical content of this release.
The Option Agreement is subject to the approval of the TSX-Venture Exchange.
On behalf of the Board of Directors:
'Andrew Mah'
Andrew Mah, President & Director
(604)763 7748 (cell) or (604)288 2756
andrew.mah@cavanventures.com
or
Patrick Brandreth
Director, Corporate communication: (604) 809 3527
patrick@cavanventures.com
For further information please visit our website at www.cavanventures.com
This news release contains certain forward-looking statements that reflect the current views and/or expectations of Cavan with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Twitter: www.twitter.com/cavanventures
Facebook: www.facebook.com/cavanventures
Vancouver, British Columbia, CANADA - May 6, 2011 (Investorideas.com Newswire) - Cavan Ventures Inc. (TSX.V-CVN), (http://www.cavanventures.com) (the 'Company') is pleased to announce it has entered into a Mining Option Agreement with Q-Gold Resources Ltd. (TSX.V-QGR) ('Q-Gold') (http://www.qgoldresources.com) whereby Cavan has obtained an 18-month option to earn a 65% participating interest in a prospective Arizona silver joint venture with Q-Gold.
The joint venture will contain Q-Gold's holdings of 3 patented historic silver mines and 22 adjoining U.S. Bureau of Land Management ('BLM') mining claims in the Peck Mining District of Yavapai County, Arizona, totalling 484 acres. The Peck District is famous for its historic high-grade silver production, having produced an 'official' 1,374,000 ounces from 1875 to 1910.
Q-Gold's holdings include the historic 'Black Warrior', 'Isis' and a portion of the 'Silver Prince' silver mines, all of which produced high-grade silver ores during the above period, using primitive mining methods.
As Arizona only became a state in 1912, production records are scarce and difficult to obtain. However, 'Territorial' records show silver production worth $500,000 during the above period from the Black Warrior and the Silver Prince Mines, a portion of the latter which is included in the Agreement. High-grade ore, occurring in ore shoots, went directly to the smelter, with 'milling grade' ore production assaying at 12-16 ounces of silver per ton being crushed and concentrated on site. The mines were closed early in the 20th Century due to the 'Silver Price Depression' and the advent of World War I and have never been re-opened.
By meeting its obligations in U.S. Dollars during the 18-month Option Period, including cash payments to Q-Gold of $275,000, work expenditures of $1,000,000 and issuance of Cavan shares to Q-Gold worth $300,000, Cavan will earn a 65% participating interest in the Joint Venture. During the Option Period, Q-Gold will be Operator for the undertaking.
The known silver mineralization in the Black Warrior and Silver Prince Mines occurs in 'saddle reef' or lenticular deposits in host granites and schists, along vein structures from 50 to 250 feet in width and from 2 to 18 feet in thickness. These occur at depths between 200 and 400 feet. On the property are 5 veins, only two of which have been worked to any extent. Two adits and one shaft were entered and inspected by Q-Gold's geologist, and all contained silver and antimony mineralization. The deposits contain the important silver ore minerals, argentite and pyrargyrite, as well as argentiferous galena and antimonial silver minerals, the latter in their deeper portions. The secondarily leached silver minerals miargyrite, iodargyrite and bromargyrite, were also encountered in the adits.
As noted above, the area contains 3 high grade historic silver mines and a number of BLM claims highly prospective for silver, yet it has never experienced modern mining exploration techniques. Therefore, the venture will initially launch a helicopter-based VTEM / Magnetic airborne geophysical survey which will attempt to delineate anomalies which will indicate potential remaining ore bodies and possible drilling sites within the complex.
Mr. Andrew Mah remarked 'With silver prices at recent record highs, I look forward to initiating modern joint exploration activities this summer with Q-Gold in the historic silver-producing Peck Mining District of Arizona.'
The historical references contained in this release have not been verified by a qualified person under NI 43-101 and therefore cannot be relied on for any purpose. Brian A. Beck, PG a qualified person under NI 43-101 has reviewed and approved the technical content of this release.
The Option Agreement is subject to the approval of the TSX-Venture Exchange.
On behalf of the Board of Directors:
'Andrew Mah'
Andrew Mah, President & Director
(604)763 7748 (cell) or (604)288 2756
andrew.mah@cavanventures.com
or
Patrick Brandreth
Director, Corporate communication: (604) 809 3527
patrick@cavanventures.com
For further information please visit our website at www.cavanventures.com
This news release contains certain forward-looking statements that reflect the current views and/or expectations of Cavan with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Twitter: www.twitter.com/cavanventures
Facebook: www.facebook.com/cavanventures
Mining and Gold Stock Trueclaim Exploration Inc. (TSX-V: TRM) (OTCQX: TRMNF) Added to Growing List of Mining Companies Speaking at May 25th Online Mining Investment Conference
May 6, 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor stock research announce the addition of Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM), to the growing list of mining stocks and industry speakers for this months online mining investor conference . The company is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.
Mining company, Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock at online mining conference, Follow the Money in Mining and Metals, May 25 th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Goldcorp (TSX: G, NYSE: GG)
Goldcorp is the fastest growing, lowest-cost senior gold producer with operations and development projects in politically stable jurisdictions throughout the Americas. Our strong project pipeline is positioned to drive long-term, sustainable growth. A Canadian company headquartered in Vancouver, British Columbia, Goldcorp employs more than 11,500 people worldwide. Goldcorp is committed to responsible mining practices and is well-positioned to deliver sustained, industry leading growth and performance. We endeavor to deliver sustainable prosperity for our shareholders, employees, business partners and the communities in which we operate.
Contact
Jeff Wilhoit
VP, Investor Relations
(604) 696-3074
info@goldcorp.com
www.goldcorp.com
Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM)
Trueclaim Exploration Inc. is a mineral exploration company. Trueclaim is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.The Company's current principal project is the former Scadding Gold Mine near Sudbury, Ontario. The Scadding claims are part of approximately 45,000 acres the Company has assembled in this area.
Contact
Jim Elbert
jelbert@trueclaim.ca
www.trueclaimexploration.com
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca\
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com
May 6, 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor stock research announce the addition of Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM), to the growing list of mining stocks and industry speakers for this months online mining investor conference . The company is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.
Mining company, Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock at online mining conference, Follow the Money in Mining and Metals, May 25 th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Goldcorp (TSX: G, NYSE: GG)
Goldcorp is the fastest growing, lowest-cost senior gold producer with operations and development projects in politically stable jurisdictions throughout the Americas. Our strong project pipeline is positioned to drive long-term, sustainable growth. A Canadian company headquartered in Vancouver, British Columbia, Goldcorp employs more than 11,500 people worldwide. Goldcorp is committed to responsible mining practices and is well-positioned to deliver sustained, industry leading growth and performance. We endeavor to deliver sustainable prosperity for our shareholders, employees, business partners and the communities in which we operate.
Contact
Jeff Wilhoit
VP, Investor Relations
(604) 696-3074
info@goldcorp.com
www.goldcorp.com
Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM)
Trueclaim Exploration Inc. is a mineral exploration company. Trueclaim is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.The Company's current principal project is the former Scadding Gold Mine near Sudbury, Ontario. The Scadding claims are part of approximately 45,000 acres the Company has assembled in this area.
Contact
Jim Elbert
jelbert@trueclaim.ca
www.trueclaimexploration.com
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca\
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com
Subscribe to:
Posts (Atom)